Webinar | March 1, 2024

Scaling For Commercialization: Considerations For Large-Scale API Production

Scaling up programs from clinical development to larger batch sizes presents several challenges and complexities that need to be addressed for a successful scale-up. Key considerations such as risk mitigation, production scalability, regulatory filing support, and specialized technological capabilities should be thoroughly evaluated. Collaborating with a reliable and experienced commercial partner is crucial for program success.

MilliporeSigma's experts share insights about choosing the right Contract Development and Manufacturing Organization (CDMO) partner for large-scale API production and key considerations to ensure the success of your small molecule API program.

In this webinar, you will learn:

  • Process optimizations and efficiencies at commercial scale
  • Production scalability, from lab to plant
  • Regulatory considerations for clinical and commercial filings

Need More Information? Just Ask.

Click the button below to directly contact the supplier. Use it to:

  • Ask a question.
  • Request more detailed information or literature.
  • Discuss your current project/application.
  • Request a quote.
  • Locate a distributor in your area.
  • Schedule a demo.
Request Info
  Free Pharmaceutical Online Newsletter

MilliporeSigma